Study Stopped
Failure to maintain access to Altitude Facility
Effect of Short-term Simulated Altitude Exposure on Cardiopulmonary Functional Capacity
1 other identifier
interventional
8
0 countries
N/A
Brief Summary
To determine if exposure of older volunteers, age 50-70y, who are healthy, but not physically active, to 7 days of mild hypoxia (15% oxygen, equivalent 2440m) will improve cardiopulmonary functional capacity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2015
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2015
CompletedFirst Submitted
Initial submission to the registry
June 2, 2015
CompletedFirst Posted
Study publicly available on registry
August 14, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2015
CompletedDecember 6, 2023
April 1, 2021
5 months
June 2, 2015
December 5, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Cardio pulmonary functional variables
Assess cardio pulmonary functional variables using cardio pulmonary exercise testing (CPET) prior and following participants completing each arm of the study
Change in Cardio pulmonary functional variables between day 0 and day 7 in each arm of the study.
Study Arms (2)
Hypoxia
EXPERIMENTALMild hypoxia of 15% oxygen, equivalent altitude of 2440m over a period of 7 days
Normoxia
SHAM COMPARATORExposure to normal, sea-level air
Interventions
Participants live within an altitude residence facility. Hypoxic acclimatisation will be achieved by venting the rooms with air containing a reduced oxygen content. The degree of hypoxia is ramped over a 2-day period as participants experience 14 hours of overnight hypoxic exposure (simulating altitude of : 1830m on Day 1; 2130m on Day 2). The final 5 days will be spent entirely in the altitude residence facility at a consistent hypoxia level (simulating approximately 2440m).
Participants will live in the altitude residence facility. As a sham-control, normal sea level air will be circulated throughout the house.
Eligibility Criteria
You may qualify if:
- Healthy male and female individuals aged 50-70 years with sedentary lifestyles.
You may not qualify if:
- Known intolerance to altitude identified by the participant's clinical examination, history and pre-altitude screening completed by the research clinician.
- Non-availability and/or suitability to complete the required residential period within the altitude centre.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Limericklead
- University of Oxfordcollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Smith (Chief Investigator), MBBS, DPhil, FRCA, FAsMA
University of Oxford
- PRINCIPAL INVESTIGATOR
Phillip Jakeman, BSc, MSc, PhD
University of Limerick
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 2, 2015
First Posted
August 14, 2015
Study Start
May 1, 2015
Primary Completion
September 30, 2015
Study Completion
December 30, 2015
Last Updated
December 6, 2023
Record last verified: 2021-04